Your browser is no longer supported. Please, upgrade your browser.
SNY [NASD]
Sanofi
Index- P/E18.43 EPS (ttm)2.82 Insider Own16.40% Shs Outstand2.48B Perf Week3.47%
Market Cap128.56B Forward P/E12.14 EPS next Y4.28 Insider Trans0.00% Shs Float2.25B Perf Month5.33%
Income7.07B PEG1.79 EPS next Q0.76 Inst Own9.60% Short Float0.21% Perf Quarter6.31%
Sales44.09B P/S2.92 EPS this Y324.80% Inst Trans0.20% Short Ratio3.01 Perf Half Y1.52%
Book/sh25.24 P/B2.06 EPS next Y12.76% ROA5.80% Target Price64.12 Perf Year5.14%
Cash/sh4.50 P/C11.55 EPS next 5Y10.30% ROE10.70% 52W Range45.17 - 54.26 Perf YTD3.65%
Dividend1.93 P/FCF- EPS past 5Y24.10% ROI14.20% 52W High-4.29% Beta0.59
Dividend %3.72% Quick Ratio1.10 Sales past 5Y1.40% Gross Margin68.30% 52W Low14.97% ATR0.79
Employees99412 Current Ratio1.50 Sales Q/Q9.60% Oper. Margin22.60% RSI (14)63.17 Volatility1.43% 1.09%
OptionableYes Debt/Eq0.34 EPS Q/Q18.80% Profit Margin17.30% Rel Volume1.28 Prev Close50.73
ShortableYes LT Debt/Eq0.30 EarningsFeb 04 BMO Payout0.00% Avg Volume1.55M Price51.93
Recom1.20 SMA203.55% SMA504.27% SMA2002.20% Volume1,980,103 Change2.37%
Sep-27-21Upgrade SVB Leerink Mkt Perform → Outperform
Jan-15-21Initiated Deutsche Bank Sell
Sep-29-20Initiated Berenberg Hold
Mar-17-20Upgrade Barclays Underweight → Equal Weight
Mar-11-20Upgrade Goldman Neutral → Buy
Feb-11-20Initiated SVB Leerink Mkt Perform
Jan-06-20Upgrade JP Morgan Neutral → Overweight
Sep-23-19Upgrade Guggenheim Neutral → Buy
Sep-20-19Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-03-19Initiated Bernstein Outperform
Aug-14-19Upgrade UBS Neutral → Buy
Dec-11-18Upgrade Jefferies Hold → Buy
Nov-01-18Upgrade Barclays Underweight → Equal Weight
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Neutral → Buy
Aug-10-18Upgrade Citigroup Neutral → Buy
Mar-23-18Upgrade Liberum Hold → Buy
Jan-23-18Downgrade Barclays Equal Weight → Underweight
Dec-06-17Downgrade BofA/Merrill Buy → Neutral
Dec-01-17Downgrade Morgan Stanley Overweight → Underweight
Jan-17-22 01:38PM  
01:14PM  
09:20AM  
04:00AM  
Jan-15-22 07:50AM  
Jan-14-22 02:18PM  
Jan-13-22 01:38PM  
Jan-12-22 10:18AM  
Jan-11-22 10:38AM  
10:31AM  
09:49AM  
06:30AM  
Jan-10-22 10:44AM  
Jan-07-22 09:14AM  
07:53AM  
01:01AM  
01:00AM  
Jan-05-22 05:08AM  
Jan-04-22 01:30AM  
Dec-27-21 06:16AM  
Dec-21-21 03:52PM  
11:24AM  
07:57AM  
07:01AM  
04:41AM  
01:09AM  
Dec-20-21 11:51PM  
11:30PM  
Dec-16-21 01:03PM  
02:00AM  
Dec-15-21 11:12AM  
05:55AM  
05:03AM  
05:00AM  
02:29AM  
01:53AM  
01:30AM  
Dec-14-21 11:38PM  
12:48PM  
12:44PM  
09:00AM  
Dec-13-21 12:12PM  
12:03PM  
10:54AM  
10:33AM  
01:00AM  
Dec-10-21 04:09PM  
01:34PM  
11:16AM  
11:01AM  
08:34AM  
08:30AM  
Dec-08-21 05:30PM  
09:21AM  
Dec-07-21 05:43PM  
09:50AM  
Dec-06-21 11:51AM  
Dec-01-21 02:46PM  
01:30AM  
01:00AM  
Nov-30-21 09:05AM  
Nov-29-21 11:32AM  
Nov-22-21 10:24AM  
07:05AM  
07:00AM  
Nov-18-21 10:13AM  
08:54AM  
01:53AM  
01:45AM  
01:30AM  
Nov-16-21 10:39AM  
Nov-10-21 09:36AM  
05:21AM  
Nov-09-21 09:05AM  
Nov-08-21 07:00AM  
Nov-04-21 11:48AM  
Nov-01-21 03:21PM  
10:13AM  
Oct-31-21 02:20PM  
Oct-29-21 03:31PM  
02:33PM  
10:41AM  
07:00AM  
Oct-28-21 02:21PM  
10:46AM  
06:58AM  
01:30AM  
Oct-27-21 02:57PM  
11:10AM  
Oct-25-21 01:00AM  
Oct-22-21 03:01PM  
09:24AM  
01:00AM  
Oct-20-21 05:30PM  
02:39PM  
07:05AM  
07:00AM  
Oct-14-21 02:37PM  
Oct-13-21 02:32PM  
07:30AM  
Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. It also has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration with TrialSpark Inc. to execute clinical research studies in the areas of chronic obstructive pulmonary disease. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sanofi10% OwnerAug 02Buy15.0066,6671,000,0053,155,169Aug 02 08:34 PM